Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

The Chemours Company (CC.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-3032.2338.00Neutral
2022-04-0731.6235.00Neutral
2022-05-0233.1038.00Neutral
2022-05-1742.8241.00Neutral
2022-07-1231.7035.00Neutral
2022-07-2834.9037.00Neutral
2022-10-1126.5329.00Neutral
2023-01-1132.9631.00Neutral
2023-01-2333.9243.00Buy
2023-02-0933.5045.00Buy
2023-04-1130.1841.00Buy
2023-06-1231.4543.00Buy
2023-07-2737.9547.00Buy
2023-10-0925.8141.00Buy
2023-10-2624.2437.00Buy
2024-03-0420.1921.00Neutral
2024-04-0128.7428.00Neutral
2024-07-0922.4530.00Buy
2024-08-0518.7528.00Buy
2024-10-0720.0726.00Buy
2025-02-1817.4824.00Buy
2025-04-0710.5318.00Buy
2025-05-0612.1017.00Buy

Disclosures

  • UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and investment banking services are being, or have been, provided.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.